{"id":"CHEMBL101801","canonicalSmiles":"NC(=O)c1ccc(Nc2nc(N)c(N=O)c(OCC3CCCCC3)n2)cc1","inchiKey":"YBKLJTXDSBEVRV-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL101801","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"drugbank":["DB08572"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL107367","canonicalSmiles":"Cc1oc(-c2ccccc2)nc1CCOc1ccc(C[C@H](Nc2ccccc2C(=O)c2ccccc2)C(=O)O)cc1","inchiKey":"ZZCHHVUQYRMYLW-HKBQPEDESA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"FARGLITAZAR","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Farglitazar","G1-262570","GI-262570","GI-262570X","GI262570X","Gi262570"],"crossReferences":{"PubChem":["144210538"],"Wikipedia":["Farglitazar"]},"linkedTargets":{"rows":["ENSG00000132170"],"count":1},"linkedDiseases":{"rows":["EFO_0001422"],"count":1},"description":"Small molecule drug with a maximum clinical trial phase of II and has 1 investigational indication."}
{"id":"CHEMBL1088749","canonicalSmiles":"Nc1ccn([C@H]2C[C@H](OP(=O)(O)OC[C@H]3O[C@@H](n4cnc5c(N)ncnc54)C[C@@H]3O)[C@@H](CO)O2)c(=O)n1","inchiKey":"LYWWDKIADIGKTH-IDMWBNCISA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL1088749","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"drugbank":["DB02573"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL1088752","canonicalSmiles":"Cc1c(F)cc(C(=O)NC2CC2)cc1-c1ccc(C(=O)NCC(C)(C)C)cn1","inchiKey":"KKYABQBFGDZVNQ-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"LOSMAPIMOD","maximumClinicalTrialPhase":3,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["FTX-1821","FTX1821","GSK-AHAB","GSKAHAB","GW-856553X","GW856553","GW856553X","Gw-856553","Gw856553","Losmapimod"],"crossReferences":{"Wikipedia":["Losmapimod"],"drugbank":["DB12270"]},"linkedTargets":{"rows":["ENSG00000112062","ENSG00000185386"],"count":2},"linkedDiseases":{"rows":["EFO_0005762","EFO_0003914","EFO_0000685","MONDO_0100096","MONDO_0002009","Orphanet_269","EFO_0000341","EFO_0000319","EFO_0004236","EFO_0005672","Orphanet_309005"],"count":11},"description":"Small molecule drug with a maximum clinical trial phase of III (across all indications) and has 11 investigational indications."}
{"id":"CHEMBL1091024","canonicalSmiles":"CCC(=O)O[C@H]1[C@H](C)O[C@@H](O[C@@H]2[C@@H](C)O[C@@H](O[C@@H]3[C@@H](OC)[C@H](OC(=O)CC)CC(=O)O[C@H](C)C/C=C/C=C/[C@H](OC(C)=O)[C@H](C)C[C@@H]3CC=O)[C@H](O)[C@H]2N(C)C)C[C@@]1(C)OC(C)=O","inchiKey":"GQNZGCARKRHPOH-RQIKCTSVSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"MIOCAMYCIN","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["3'',9-diacetylmydecamycin","9,3''-di-o-acetylmidecamycin","Acecamycin","Midecamycin acetate","Midecamycin diacetate","Miocamycin","Miokamycin","Ponsinomycin"],"crossReferences":{"Wikipedia":["Miocamycin"]},"description":"Small molecule drug with a maximum clinical trial phase of I and has 1 investigational indication."}
{"id":"CHEMBL1093423","canonicalSmiles":"CCOc1ccc(Cc2cc([C@@H]3S[C@H](CO)[C@@H](O)[C@H](O)[C@H]3O)c(OC)cc2C)cc1","inchiKey":"WHSOLWOTCHFFBK-ZQGJOIPISA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL1093423","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"drugbank":["DB12214"]},"childChemblIds":["CHEMBL3781004"],"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL111659","canonicalSmiles":"C#Cc1cncc([C@@H]2CCCN2C)c1","inchiKey":"NUPUDYKEEJNZRG-LBPRGKRZSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"ALTINICLINE","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["(-)-5-ethynylnicotine","Altinicline","SIB-1508Y","SIB-1765F"],"crossReferences":{"Wikipedia":["Altinicline"]},"childChemblIds":["CHEMBL2146093"],"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL112","canonicalSmiles":"CC(=O)Nc1ccc(O)cc1","inchiKey":"RZVAJINKPMORJF-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":true,"name":"ACETAMINOPHEN","yearOfFirstApproval":1968,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Abdine","Acephen","Acetaminophen","Alvedon","Angiers","Calpol","Calpol six plus","Calpol six plus fastmelts","Child lemsip","Cupanol","Dafalgan","Datril","Disprol","Disprol infant","Disprol jnr","Disprol paed","Fennings","Galpamol","Hedex","Infadrops","Infants' feverall","Injectapap","Junior parapaed","Mandanol","Medinol","Medinol for children","Medinol over 6","Medinol under 6","Medised plain","Miradol","Neopap","Ofirmev","Paldesic","Panadol","Panadol actifast","Panadol actifast solb","Panadol advan","Panadol jnr","Panadol oa","Panaleve","Panaleve 6 plus","Paracetamol","Paramin","Parapaed jnr","Parapaed six plus","Paravict","Perfalgan","Phenaphen","Placidex","Rimadol","Salzone","Tixymol","Tramil 500","Tylenol"],"synonyms":["Acetaminophen","Apap","Biocetamol","Doliprane","Efferalgan","N-acetyl-p-aminophenol","NSC-109028","NSC-3991","P-hydroxy-acetanilid","Paracetamol","Paracetamolum","Vermidon"],"crossReferences":{"DailyMed":["acetaminophen"],"PubChem":["104171293","11112253","11114188","124882135","144209128","144210420","170466797","17390068","174007306","26747171","56422763"],"TG-GATEs":["1"],"Wikipedia":["Paracetamol"],"drugbank":["DB00316"],"chEBI":["46195"]},"linkedTargets":{"rows":["ENSG00000117480","ENSG00000073756","ENSG00000196689","ENSG00000095303"],"count":4},"linkedDiseases":{"rows":["MONDO_0000468","EFO_0011061","EFO_0007486","EFO_0007444","HP_0000175","HP_0012228","EFO_0005952","HP_0011868","EFO_0003964","EFO_1000831","EFO_0003931","EFO_0008585","EFO_0000096","EFO_0002690","EFO_0000339","EFO_1001366","EFO_1000652","EFO_0004616","EFO_0009620","EFO_0000400","EFO_0000198","EFO_0005762","HP_0012532","HP_0012076","EFO_0010072","EFO_0004197","EFO_0000384","EFO_0000546","MP_0001914","EFO_0009260","HP_0002027","EFO_0003957","EFO_0000574","EFO_0004209","EFO_0007328","HP_0100607","EFO_0001378","EFO_0000516","MONDO_0002258","EFO_0005672","EFO_0003943","MONDO_0018373","EFO_0003086","HP_0002373","MONDO_0021117","HP_0000545","MONDO_0007254","EFO_0003882","MONDO_0005180","MONDO_0017287","EFO_0004143","EFO_1001092","EFO_1000249","EFO_0000616","EFO_0000772","EFO_0004210","EFO_0009816","EFO_0004269","EFO_1001757","EFO_0001645","EFO_0000403","HP_0011110","EFO_0000222","EFO_0003929","EFO_0000618","HP_0003418","EFO_0001073","EFO_0003843","HP_0002315","EFO_0004599","EFO_0000537","EFO_1001412","EFO_1001460","EFO_0011023","EFO_0000764","EFO_0004273","EFO_0007359","MONDO_0043510","MONDO_0005148","MONDO_0005178","EFO_0002756","EFO_0009615","EFO_0004710","MONDO_0024647","EFO_1001139","HP_0000989","EFO_1000905","EFO_0005592","HP_0001643","EFO_0000540","HP_0002018","EFO_0007160","Orphanet_365","EFO_0000544","EFO_0004253","EFO_1000786","EFO_0000389","EFO_1001898","HP_0003419","HP_0008419","EFO_1000749","EFO_1001250","EFO_0005761","EFO_1001476","EFO_0001074","EFO_0000220","EFO_0005856","HP_0100806","MONDO_0100096","EFO_0000731","HP_0030833","MONDO_0044917","EFO_0004888","EFO_0000668","EFO_0002970","Orphanet_232","MONDO_0100342","EFO_0009846","EFO_0009267","MONDO_0024355","MONDO_0005277","EFO_1000783","EFO_1001216","EFO_0002460","HP_0002013","MONDO_0007079","EFO_0005230","EFO_0000685","EFO_0004329","HP_0001945","EFO_0000677","EFO_0003060","EFO_0007214","EFO_0000311","EFO_0010282","EFO_0001068","EFO_0000095","MONDO_0005301","MONDO_0005147","MONDO_0004975","EFO_1001891","EFO_0005611","HP_0000023"],"count":143},"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 1968 and has 12 approved and 89 investigational indications. This drug has a black box warning from the FDA."}
{"id":"CHEMBL1162175","canonicalSmiles":"CCNC(=O)Nc1ncnc2c1ncn2[C@@H]1O[C@H](COP(=O)(O)O)[C@H]2O[C@H](/C=C/c3ccccc3)O[C@H]21","inchiKey":"NXHAXEBZOXCDKD-XIXRRVGJSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"REGRELOR","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Regrelor"],"crossReferences":{"drugbank":["DB05553"]},"childChemblIds":["CHEMBL261244"],"linkedTargets":{"rows":["ENSG00000169313"],"count":1},"linkedDiseases":{"rows":["EFO_0001645","EFO_0000319"],"count":2},"description":"Small molecule drug with a maximum clinical trial phase of II (across all indications) and has 2 investigational indications."}
{"id":"CHEMBL117658","canonicalSmiles":"CCCC[C@@H](C=O)NC(=O)OC1(Cc2ccccc2)CCCC1","inchiKey":"ONABDOMWRCXLPX-KRWDZBQOSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL117658","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"drugbank":["DB07593"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL1178725","canonicalSmiles":"CC(C)Oc1cccc(CC(=O)N2CCC[C@](CC[N+]34CCC(c5ccccc5)(CC3)CC4)(c3ccc(Cl)c(Cl)c3)C2)c1","inchiKey":"RPDFDSQFBCJTDY-GAQXSTBRSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"NOLPITANTIUM","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Nolpitantium","Nolpitantium cation","Nolpitantium ion","Sr-140333"],"childChemblIds":["CHEMBL2105831","CHEMBL38763"],"description":"Small molecule drug with a maximum clinical trial phase of II and has 1 investigational indication."}
{"id":"CHEMBL1187319","canonicalSmiles":"O=C(N[C@H]1CCCNC1)c1n[nH]cc1NC(=O)c1c(F)cccc1F","inchiKey":"KOMNQBZWMCFDTQ-VIFPVBQESA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL1187319","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"drugbank":["DB08141"]},"childChemblIds":["CHEMBL498659"],"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL1200357","canonicalSmiles":"CO[C@@]1(NC(=O)C(C(=O)[O-])c2ccc(O)cc2)C(=O)N2C(C(=O)[O-])=C(CSc3nnnn3C)CO[C@@H]21.[Na+].[Na+]","inchiKey":"GRIXGZQULWMCLU-HUTAOCTPSA-L","drugType":"Small molecule","blackBoxWarning":false,"name":"MOXALACTAM DISODIUM","yearOfFirstApproval":1982,"maximumClinicalTrialPhase":4,"parentId":"CHEMBL74632","hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Moxam","Shiomarin"],"synonyms":["Disodium latamoxef","LY-127935","LY127935","Latamoxef disodium","Latamoxef sodium","Latamoxefum dinatricum","Moxalactam disodium","Moxalactam disodium salt","NSC-757107","Shiomarin"],"crossReferences":{"PubChem":["144204344","170465353"]},"description":"Small molecule drug with a maximum clinical trial phase of IV that was first approved in 1982."}
{"id":"CHEMBL1200381","canonicalSmiles":"Cl.N=C(N)NCCC[C@H](N)C(=O)O","inchiKey":"KWTQSFXGGICVPE-WCCKRBBISA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"ARGININE HYDROCHLORIDE","maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["R-gene 10"],"synonyms":["Arginine hcl","Arginine hydrochloride","L-arginine hcl","L-arginine hydrochloride","NSC-203450","NSC-7914"],"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) and is indicated for pituitary dwarfism and has 3 investigational indications."}
{"id":"CHEMBL1200541","canonicalSmiles":"CC[N+](CC)(CCNC(=O)C(=O)NCC[N+](CC)(CC)Cc1ccccc1Cl)Cc1ccccc1Cl.[Cl-].[Cl-]","inchiKey":"DXUUXWKFVDVHIK-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"AMBENONIUM CHLORIDE","yearOfFirstApproval":1956,"maximumClinicalTrialPhase":4,"parentId":"CHEMBL1652","hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Mytelase"],"synonyms":["Ambenonium chloride"],"crossReferences":{"PubChem":["144205583","170465386"],"chEBI":["2628"]},"description":"Small molecule drug with a maximum clinical trial phase of IV that was first approved in 1956."}
{"id":"CHEMBL1200542","canonicalSmiles":"CC(=O)OCC(=O)[C@H]1CC[C@H]2[C@@H]3CCC4=CC(=O)CC[C@]4(C)[C@H]3CC[C@]12C","inchiKey":"VPGRYOFKCNULNK-ACXQXYJUSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"DESOXYCORTICOSTERONE ACETATE","yearOfFirstApproval":1939,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Doca","Percorten"],"synonyms":["11-deoxycorticosterone","11-deoxycorticosterone acetate","21-hydroxyprogesterone","Deoxycorticosterone","Deoxycorticosterone acetate","Deoxycortone","Desoxycorticosterone","Desoxycorticosterone acetate","Desoxycortone","Desoxycortone acetate","NSC-11319","NSC-9567"],"crossReferences":{"PubChem":["144204427","170465334","29215003","56422097","855662"],"drugbank":["DB06780"],"chEBI":["34671"]},"linkedTargets":{"rows":["ENSG00000151623"],"count":1},"linkedDiseases":{"rows":["HP_0002619","EFO_1001434"],"count":2},"description":"Small molecule drug with a maximum clinical trial phase of IV that was first approved in 1939."}
{"id":"CHEMBL1200724","canonicalSmiles":"CN[C@@H](C)[C@@H](O)c1ccccc1.Cl","inchiKey":"BALXUFOVQVENIU-KXNXZCPBSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"PSEUDOEPHEDRINE HYDROCHLORIDE","yearOfFirstApproval":1975,"maximumClinicalTrialPhase":4,"parentId":"CHEMBL1590","hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Actifed","Contac","Dimotane plus","Dimotane plus l.a.","Galpseud","Galpseud plus","Novafed","Otrivine mu-cron","Pseudoephedrine hydrochloride","Pseudophed","Sinutab","Sudafed","Sudafed 12 hour","Sudafed 12 hr decongest","Sudafed 24 hour","Sudafed plus","Sudafed-sa"],"synonyms":["Efidac 24","Galsud","NSC-106567","NSC-33634","Otrinol","Pseudoephedrine hcl","Pseudoephedrine hydrochloride","Rhinalair"],"crossReferences":{"DailyMed":["pseudoephedrine%20hydrochloride"],"PubChem":["50086711","544025"],"chEBI":["8604"]},"linkedTargets":{"rows":["ENSG00000103546"],"count":1},"linkedDiseases":{"rows":["EFO_0005854","MONDO_0005277","EFO_0007486","HP_0012735","MONDO_0024290","MONDO_0005271","EFO_0007328","HP_0001742","EFO_0003843","EFO_0007214","EFO_0003956"],"count":11},"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 1975 and has 10 approved and 1 investigational indication."}
{"id":"CHEMBL1200745","canonicalSmiles":"C=CCOc1ccccc1OCC(O)CNC(C)C.Cl","inchiKey":"COAJXCLTPGGDAJ-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"OXPRENOLOL HYDROCHLORIDE","yearOfFirstApproval":1983,"maximumClinicalTrialPhase":4,"parentId":"CHEMBL546","hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Apsolox","Laracor","Oxyprenix excel 160","Paritane","Slow-pren","Slow-trasicor","Trasicor","Trasicor ret"],"synonyms":["BA-39,089","BA-39089","Oxprenolol hcl","Oxprenolol hydrochloride"],"crossReferences":{"PubChem":["144204107","170464995","56463641"]},"description":"Small molecule drug with a maximum clinical trial phase of IV that was first approved in 1983."}
{"id":"CHEMBL1201057","canonicalSmiles":"CC1(C)C[C@@H]1C(=O)N/C(=C\\CCCCSC[C@H](N)C(=O)O)C(=O)[O-].[Na+]","inchiKey":"QXPBTTUOVWMPJN-QBNHLFMHSA-M","drugType":"Small molecule","blackBoxWarning":false,"name":"CILASTATIN SODIUM","yearOfFirstApproval":1985,"maximumClinicalTrialPhase":4,"parentId":"CHEMBL766","hasBeenWithdrawn":false,"isApproved":true,"tradeNames":[],"synonyms":["Cilastatin sodium","Cilastatin sodium salt","MK-791"],"crossReferences":{"DailyMed":["cilastatin%20sodium"],"PubChem":["144206357","49732002"],"chEBI":["59511"]},"linkedTargets":{"rows":["ENSG00000015413"],"count":1},"linkedDiseases":{"rows":["EFO_0003106","HP_0100806","EFO_0003103","EFO_0000544","EFO_0000465"],"count":5},"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 1985 and has 5 approved indications."}
{"id":"CHEMBL1201058","canonicalSmiles":"CC(=O)[O-].[K+]","inchiKey":"SCVFZCLFOSHCOH-UHFFFAOYSA-M","drugType":"Small molecule","blackBoxWarning":false,"name":"POTASSIUM ACETATE","maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Potassium acetate"],"synonyms":["Acetic acid, potassium salt","E-261","E261","FEMA NO. 2920","INS NO.261","INS-261","INS-261(I)","Kali aceticum","Potassium acetate","Potassium acetates"],"crossReferences":{"DailyMed":["potassium%20acetate"],"DrugCentral":["4217"],"Wikipedia":["Potassium_acetate"],"drugbank":["DB14498"],"chEBI":["32029"]},"description":"Small molecule drug with a maximum clinical trial phase of IV."}
{"id":"CHEMBL1201360","canonicalSmiles":"C[C@H]1C[C@H]2[C@@H]3C[C@H](F)C4=CC(=O)C=C[C@]4(C)[C@@]3(F)[C@@H](O)C[C@]2(C)[C@@]1(O)C(=O)CCl","inchiKey":"LEHFPXVYPMWYQD-XHIJKXOTSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"HALOBETASOL","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Halobetasol"],"crossReferences":{"Wikipedia":["Ulobetasol"],"drugbank":["DB00596"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL1201485","drugType":"Small molecule","blackBoxWarning":true,"name":"SOYBEAN OIL","maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Intralipid","Liposyn Iii","Nutrilipid","Soyacal","Travamulsion"],"synonyms":["Glycine max seed oil","Intralipid (fresenius)","Liposyn (hospira)","Nutrilipid (b braun)","Soybean oil","Soybean oil, refined"],"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) and has 20 investigational indications. This drug has a black box warning from the FDA."}
{"id":"CHEMBL1201486","drugType":"Small molecule","blackBoxWarning":true,"name":"QUINIDINE POLYGALACTURONATE","yearOfFirstApproval":1982,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Cardioquin"],"synonyms":["Galactoquin","Naticardina","Quinidine polygalacturonate"],"linkedTargets":{"rows":["ENSG00000185313","ENSG00000153253","ENSG00000183873","ENSG00000136546","ENSG00000144285","ENSG00000169432","ENSG00000168356","ENSG00000136531","ENSG00000007314","ENSG00000196876"],"count":10},"linkedDiseases":{"rows":["EFO_0004269"],"count":1},"description":"Small molecule drug with a maximum clinical trial phase of IV that was first approved in 1982 and is indicated for cardiac arrhythmia. This drug has a black box warning from the FDA."}
{"id":"CHEMBL1201489","drugType":"Protein","blackBoxWarning":false,"name":"SERACTIDE ACETATE","yearOfFirstApproval":1978,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Acthar gel-synthetic"],"synonyms":["Seractide acetate","Seractide acetate hydrate"],"description":"Protein drug with a maximum clinical trial phase of IV that was first approved in 1978."}
{"id":"CHEMBL1201867","drugType":"Unknown","blackBoxWarning":true,"name":"FERUMOXYTOL","yearOfFirstApproval":2009,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Feraheme","Rienso"],"synonyms":["CODE 7228","CODE-7228","Ferumoxytol","RIENSO"],"crossReferences":{"DailyMed":["ferumoxytol"],"DrugCentral":["5204"],"Wikipedia":["Iron(II,III)_oxide"]},"description":"Unknown drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 2009 and is indicated for anemia and anemia (phenotype) and has 5 investigational indications. This drug has a black box warning from the FDA."}
{"id":"CHEMBL1229846","canonicalSmiles":"OCCOc1ccccc1","inchiKey":"QCDWFXQBSFUVSP-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"PHENOXYETHANOL","maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":[],"synonyms":["FEMA NO. 4620","NSC-1864","Phenoxethol","Phenoxyethanol","Phenyl cellosolve"],"crossReferences":{"PubChem":["144204553","144209309","144211159","170465671","17389580","26752767","26752768","56463731"],"Wikipedia":["Phenoxyethanol"],"drugbank":["DB11304"],"chEBI":["64275"]},"description":"Small molecule drug with a maximum clinical trial phase of IV."}
{"id":"CHEMBL1230674","canonicalSmiles":"Cn1cnc2c(O)nc(N)nc21","inchiKey":"UUWJNBOCAPUTBK-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"9-Methylguanine","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["9-Methylguanine"],"crossReferences":{"PubChem":["144210126"],"drugbank":["DB02489"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL1231240","canonicalSmiles":"O=C1N=C(O)NC(=O)[C@@]1(c1ccccc1)N1CCC(CCO)CC1","inchiKey":"IPBPOBHSNJFRFT-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL1231240","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"drugbank":["DB03622"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL1232586","canonicalSmiles":"COCCOCCOCCOCCO","inchiKey":"ZNYRFEPBTVGZDN-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL1232586","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"PubChem":["144207946"],"drugbank":["DB04332"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL1233","canonicalSmiles":"CCCC(C)(COC(N)=O)COC(=O)NC(C)C","inchiKey":"OFZCIYFFPZCNJE-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CARISOPRODOL","yearOfFirstApproval":1959,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":true,"isApproved":true,"withdrawnNotice":{"countries":["European Union"],"classes":["Misuse"],"year":2007},"tradeNames":["Carisoma","Carisoprodol","Rela","Soma"],"synonyms":["Carisoprodol","Carisoprodol civ","NSC-172124"],"crossReferences":{"DailyMed":["carisoprodol"],"PubChem":["124879774","144203673","144207821","170465436","17389120","174006896","26752303","50105222","56424069","85230985","855912","90341406"],"Wikipedia":["Carisoprodol"],"drugbank":["DB00395"],"chEBI":["3419"]},"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 1959 and is indicated for pain and muscle spasm and has 1 investigational indication. It was withdrawn in European Union  in 2007 due to Misuse."}
{"id":"CHEMBL1234599","canonicalSmiles":"CC(=O)N1CCC[C@H]1C(=O)O","inchiKey":"GNMSLDIYJOSUSW-LURJTMIESA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL1234599","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"PubChem":["24839128"],"drugbank":["DB03360"],"chEBI":["21560"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL1235423","canonicalSmiles":"O=C1[C@@H](NS(=O)(=O)c2cc3ncccc3s2)CCN1Cc1cc2ccncc2[nH]1","inchiKey":"PLXOQMHGHDZMSX-AWEZNQCLSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL1235423","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"drugbank":["DB08426"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL1236188","canonicalSmiles":"NC(=S)c1ccc[n+]([C@@H]2O[C@H](CO[P@@](=O)([O-])O[P@](=O)(O)OC[C@H]3O[C@@H](n4cnc5c(N)ncnc54)[C@H](OP(=O)(O)O)[C@@H]3O)[C@@H](O)[C@H]2O)c1","inchiKey":"OJNFDOAQUXJWED-NNYOXOHSSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL1236188","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"drugbank":["DB01763"]},"childChemblIds":["CHEMBL1255844"],"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL1236539","canonicalSmiles":"CN[C@@H]1C[C@H]2O[C@@](C)([C@@H]1OC)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)N[C@@H]4O","inchiKey":"PBCZSGKMGDDXIJ-HQCWYSJUSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"7-Hydroxystaurosporine","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["7-Hydroxystaurosporine"],"crossReferences":{"PubChem":["499504"],"drugbank":["DB01933"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL1374738","canonicalSmiles":"O=C1OCCN1N=Cc1ccc([N+](=O)[O-])o1","inchiKey":"PLHJDBGFXBMTGZ-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL1374738","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"PubChem":["50085998","8139923"],"drugbank":["DB00614"],"chEBI":["5195"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL141","canonicalSmiles":"Nc1ccn([C@@H]2CS[C@H](CO)O2)c(=O)n1","inchiKey":"JTEGQNOMFQHVDC-NKWVEPMBSA-N","drugType":"Small molecule","blackBoxWarning":true,"name":"LAMIVUDINE","yearOfFirstApproval":1995,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Epivir","Epivir-hbv","Lamivudine","Zeffix"],"synonyms":["BCH 189, (-)-","Epivir","GR 109714X","GR-109714X","Lamivudine","Lamivudine teva","Lamivudinum","NSC-760061","Virolam"],"crossReferences":{"DailyMed":["lamivudine"],"PubChem":["29215254","49681736"],"Wikipedia":["Lamivudine"],"drugbank":["DB00709"],"chEBI":["63577"]},"childChemblIds":["CHEMBL537885"],"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 1995 and has 9 approved and 12 investigational indications. This drug has a black box warning from the FDA."}
{"id":"CHEMBL1410743","canonicalSmiles":"CC1OC(C)OC(C)O1","inchiKey":"SQYNKIJPMDEDEG-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"PARALDEHYDE","maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Paral"],"synonyms":["2,4,6-trimethyl-s-trioxane","FEMA NO. 4010","NSC-9799","Paracetaldehyde","Paraldehyde","Paraldehyde civ"],"crossReferences":{"PubChem":["144205161","144211616","170465660","29215288","50109849"],"Wikipedia":["Paraldehyde"],"drugbank":["DB09117"],"chEBI":["27909"]},"description":"Small molecule drug with a maximum clinical trial phase of IV and has 1 investigational indication."}
{"id":"CHEMBL1449","canonicalSmiles":"CC1(C)S[C@@H]2[C@H](NC(=O)[C@H](C(=O)O)c3ccsc3)C(=O)N2[C@H]1C(=O)O","inchiKey":"OHKOGUYZJXTSFX-KZFFXBSXSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"TICARCILLIN","yearOfFirstApproval":1976,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":[],"synonyms":["Ticarcillin"],"crossReferences":{"Wikipedia":["Ticarcillin"],"drugbank":["DB01607"],"chEBI":["9587"]},"childChemblIds":["CHEMBL3989647","CHEMBL3765148","CHEMBL1200855"],"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 1976 and is indicated for infection and bacterial disease and has 3 investigational indications."}
{"id":"CHEMBL146554","canonicalSmiles":"CC(C)C(=O)C(=O)O","inchiKey":"QHKABHOOEWYVLI-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"2-Oxoisovalerate","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["2-Oxoisovalerate","alpha-Ketoisovalerate","alpha-Oxoisovalerate"],"crossReferences":{"Wikipedia":["Alpha-Ketoisovaleric_acid"],"drugbank":["DB04074"],"chEBI":["16530"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL1507567","canonicalSmiles":"CC(=O)OCC(=O)[C@@]1(O)CC[C@H]2[C@@H]3CCC4=CC(=O)C=C[C@]4(C)[C@H]3C(=O)C[C@@]21C","inchiKey":"MOVRKLZUVNCBIP-RFZYENFJSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL1507567","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"PubChem":["49645975"],"drugbank":["DB14646"],"chEBI":["34655"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL1603","canonicalSmiles":"CN(N=O)C(=O)N[C@H]1[C@@H](O)O[C@H](CO)[C@@H](O)[C@@H]1O","inchiKey":"ZSJLQEPLLKMAKR-GKHCUFPYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"STREPTOZOSIN","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"PubChem":["144209057","144213291","170464827"],"drugbank":["DB00428"],"chEBI":["9288"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL1614710","canonicalSmiles":"O=C(Nc1ccc(OC(F)(F)F)cc1)c1sccc1NCc1ccnc2ccccc12","inchiKey":"FGTCROZDHDSNIO-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"OSI-930","maximumClinicalTrialPhase":1,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["OSI-930","Osi 930","Osi-930"],"crossReferences":{"PubChem":["137276003"],"drugbank":["DB05913"]},"linkedTargets":{"rows":["ENSG00000128052","ENSG00000102755","ENSG00000037280","ENSG00000157404"],"count":4},"linkedDiseases":{"rows":["EFO_0000616"],"count":1},"description":"Small molecule drug with a maximum clinical trial phase of I and has 1 investigational indication."}
{"id":"CHEMBL164660","canonicalSmiles":"O=c1ccc2cc3ccoc3cc2o1","inchiKey":"ZCCUUQDIBDJBTK-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"PSORALEN","maximumClinicalTrialPhase":1,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Ficusin","NSC-404562","Psoralen"],"crossReferences":{"PubChem":["11113270","26754320","50085967"],"Wikipedia":["Psoralen"],"chEBI":["27616"]},"description":"Small molecule drug with a maximum clinical trial phase of I (across all indications) and has 3 investigational indications."}
{"id":"CHEMBL1660","canonicalSmiles":"CO[C@H]1/C=C/O[C@@]2(C)Oc3c(C)c(O)c4c(O)c(c(/C=N/N5CCN(C6CCCC6)CC5)c(O)c4c3C2=O)NC(=O)/C(C)=C\\C=C\\[C@H](C)[C@H](O)[C@@H](C)[C@@H](O)[C@@H](C)[C@H](OC(C)=O)[C@@H]1C","inchiKey":"WDZCUPBHRAEYDL-GZAUEHORSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"RIFAPENTINE","yearOfFirstApproval":1998,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Priftin"],"synonyms":["ANTIBIOTIC DL-473IT","DL-473","KTC-1","MDL 473","MDL-473","Prifitin","R-77-3","R-773","Rifapentin","Rifapentine"],"crossReferences":{"DailyMed":["rifapentine"],"PubChem":["144205988"],"Wikipedia":["Rifapentine"],"drugbank":["DB01201"],"chEBI":["45304"]},"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 1998 and is indicated for tuberculosis and has 3 investigational indications."}
{"id":"CHEMBL1742997","drugType":"Antibody","blackBoxWarning":false,"name":"CANTUZUMAB MERTANSINE","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Cantuzumab mertansine","HUC-242-DM1","HUC242-DM1","SB-408075"],"description":"Antibody drug with a maximum clinical trial phase of II."}
{"id":"CHEMBL1743004","drugType":"Antibody","blackBoxWarning":false,"name":"CRENEZUMAB","maximumClinicalTrialPhase":3,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Crenezumab","MABT-5102A","MABT5102A","RG-7412","RG7412"],"linkedTargets":{"rows":["ENSG00000142192"],"count":1},"linkedDiseases":{"rows":["MONDO_0004975"],"count":1},"description":"Antibody drug with a maximum clinical trial phase of III and has 1 investigational indication."}
{"id":"CHEMBL1743019","drugType":"Antibody","blackBoxWarning":false,"name":"FIGITUMUMAB","maximumClinicalTrialPhase":3,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["871","CP-751","CP-751,871","CP-751871","Figitumumab"],"linkedTargets":{"rows":["ENSG00000140443"],"count":1},"linkedDiseases":{"rows":["EFO_0003869","EFO_0006859","MONDO_0021117","MONDO_0007254","EFO_0003060","EFO_0000311","EFO_0000174","EFO_0004142","EFO_0000673","EFO_0000702","EFO_0001378","EFO_0000707","EFO_0003050","EFO_0000691"],"count":14},"description":"Antibody drug with a maximum clinical trial phase of III (across all indications) and has 14 investigational indications."}
{"id":"CHEMBL180517","canonicalSmiles":"CCc1c2cc(O)ccc2nn1-c1ccc(O)cc1","inchiKey":"XBMVVMYGKMGLJX-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL180517","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"drugbank":["DB07712"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL1899801","canonicalSmiles":"FC(F)(F)C(F)(F)C(F)(F)C(F)(F)C(F)(F)F","inchiKey":"NJCBUSHGCBERSK-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"PERFLENAPENT","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Echogen","FC41-12 (PERFLENAPENT/PERFLISOPENT MIXTURE)","NVX-108","Nvx-108","Perflenapent"],"crossReferences":{"PubChem":["144205977","50112673"],"drugbank":["DB11625"],"chEBI":["39428"]},"description":"Small molecule drug with a maximum clinical trial phase of II and has 1 investigational indication."}
{"id":"CHEMBL1922673","canonicalSmiles":"CCOc1ccc(-c2ccc(Cn3c(CC(C)(C)C(=O)[O-])c(SC(C)(C)C)c4cc(OCc5ccc(C)cn5)ccc43)cc2)cn1.[Na+]","inchiKey":"NOJNFULGOQGBKB-UHFFFAOYSA-M","drugType":"Small molecule","blackBoxWarning":false,"name":"FIBOFLAPON SODIUM","maximumClinicalTrialPhase":3,"parentId":"CHEMBL1922660","hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["AM-803 SODIUM","Am803 sodium","Fiboflapon sodium","GSK-2190915A","GSK2190915A","SODIUM SALT"],"linkedTargets":{"rows":["ENSG00000132965"],"count":1},"linkedDiseases":{"rows":["EFO_0000289","Orphanet_586","MONDO_0004979","EFO_1001348"],"count":4},"description":"Small molecule drug with a maximum clinical trial phase of III (across all indications) and has 3 investigational indications."}
{"id":"CHEMBL1946186","canonicalSmiles":"CN1[C@H]2CC[C@@H]1C[C@H](OC1c3ccccc3CCc3ccccc31)C2","inchiKey":"ZWPODSUQWXAZNC-PMOLBWCYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"DEPTROPINE","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Deptropine","Dibenzheptropine"],"crossReferences":{"drugbank":["DB13466"],"chEBI":["50189"]},"childChemblIds":["CHEMBL2107603"],"description":"Small molecule drug with a maximum clinical trial phase of I and has 1 investigational indication."}
{"id":"CHEMBL1951575","canonicalSmiles":"CC(C)(C)NC(=O)c1ccc(Oc2cc(F)c(CC(=O)O)cc2Cl)c(NS(=O)(=O)c2ccc(C3CC3)cc2Cl)c1","inchiKey":"PFWVGKROPKKEDW-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"VIDUPIPRANT","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["AMG 853","AMG-853","Vidupiprant"],"crossReferences":{"drugbank":["DB12272"]},"linkedTargets":{"rows":["ENSG00000168229","ENSG00000183134"],"count":2},"linkedDiseases":{"rows":["MONDO_0004979"],"count":1},"description":"Small molecule drug with a maximum clinical trial phase of II and has 1 investigational indication."}
{"id":"CHEMBL199441","canonicalSmiles":"O=C(O)c1ccc(-c2ccccc2OC(F)(F)F)o1","inchiKey":"PSLFQKRPFOCZHR-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL199441","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"drugbank":["DB07304"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL200495","canonicalSmiles":"CCCc1c(OCCCOc2ccc3c(ccn3CC(=O)O)c2)ccc2c(C(F)(F)F)noc12","inchiKey":"TWVYNPULGKGJOS-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL200495","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"drugbank":["DB07053"]},"childChemblIds":["CHEMBL120554"],"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL204656","canonicalSmiles":"COc1cc2c(cc1Cc1cccc(Cl)c1F)c(=O)c(C(=O)O)cn2[C@H](CO)C(C)C","inchiKey":"JUZYLCPPVHEVSV-LJQANCHMSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"ELVITEGRAVIR","yearOfFirstApproval":2012,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Vitekta"],"synonyms":["Elvitegravir","GS-9137","JTK-303"],"crossReferences":{"DailyMed":["elvitegravir"],"Wikipedia":["Elvitegravir"],"drugbank":["DB09101"],"chEBI":["72289"]},"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 2012 and has 3 approved and 2 investigational indications."}
{"id":"CHEMBL2068724","canonicalSmiles":"CC(=O)NCCCS(=O)(=O)[O-].CC(=O)NCCCS(=O)(=O)[O-].[Ca+2]","inchiKey":"BUVGWDNTAWHSKI-UHFFFAOYSA-L","drugType":"Small molecule","blackBoxWarning":false,"name":"ACAMPROSATE CALCIUM","yearOfFirstApproval":2004,"maximumClinicalTrialPhase":4,"parentId":"CHEMBL1201293","hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Acamprosate calcium","Campral","Campral ec"],"synonyms":["Acamprosate calcium","NSC-759186","SN-102"],"crossReferences":{"DailyMed":["acamprosate%20calcium"],"PubChem":["144206019","144212923"],"chEBI":["51042"]},"linkedTargets":{"rows":["ENSG00000183454","ENSG00000273079","ENSG00000116032","ENSG00000109158","ENSG00000145863","ENSG00000187730","ENSG00000011677","ENSG00000151834","ENSG00000145864","ENSG00000198785","ENSG00000166206","ENSG00000182256","ENSG00000102287","ENSG00000161509","ENSG00000022355","ENSG00000105464","ENSG00000094755","ENSG00000268089","ENSG00000113327","ENSG00000163285","ENSG00000176884","ENSG00000186297","ENSG00000163288"],"count":23},"linkedDiseases":{"rows":["MONDO_0007079"],"count":1},"description":"Small molecule drug with a maximum clinical trial phase of IV that was first approved in 2004 and is indicated for alcohol dependence."}
{"id":"CHEMBL2103862","canonicalSmiles":"O=C(c1ccc(CN2CCOCC2)cc1)N1CCN(C2CC2)CC1","inchiKey":"BGBVSGSIXIIREO-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"BAVISANT","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Bavisant","JNJ-31001074"],"crossReferences":{"drugbank":["DB12299"]},"childChemblIds":["CHEMBL3577957","CHEMBL2105715"],"linkedTargets":{"rows":["ENSG00000101180"],"count":1},"linkedDiseases":{"rows":["EFO_0003888","MONDO_0007079"],"count":2},"description":"Small molecule drug with a maximum clinical trial phase of II (across all indications) and has 2 investigational indications."}
{"id":"CHEMBL2107913","drugType":"Protein","blackBoxWarning":false,"name":"OPEBACAN","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Bactericidal permeability-increasing protein opebacan","Neuprex","Opebacan","RBPI-21","Rbpi21"],"description":"Protein drug with a maximum clinical trial phase of II and has 1 investigational indication."}
{"id":"CHEMBL2108350","drugType":"Protein","blackBoxWarning":false,"name":"CONESTAT ALFA","maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":[],"synonyms":["C1 esterase inhibitor","Complement c1 esterase inhibitor","Conestat alfa","Recombinant human c1 inhibitor","Recombinant human c1-inhibitor","Rhucin","Ruconest"],"crossReferences":{"DrugCentral":["5152"]},"description":"Protein drug with a maximum clinical trial phase of IV (across all indications) and is indicated for hereditary angioedema and has 5 investigational indications."}
{"id":"CHEMBL2108451","drugType":"Oligosaccharide","blackBoxWarning":false,"name":"DEXTRAN 70","maximumClinicalTrialPhase":3,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":["Aquasite"],"synonyms":["Dextran 70","Dextran hm","Dextran, high molecular weight","Dextran-70","Dextran-hm","Macrodex"],"description":"Oligosaccharide drug with a maximum clinical trial phase of III (across all indications) and has 3 investigational indications."}
{"id":"CHEMBL2108623","drugType":"Unknown","blackBoxWarning":false,"name":"MILK THISTLE","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["822i9lej7s","Blessed milk-thistle whole","Blessed milkthistle whole","Cardui mariae fructus","Carduus lactifolius whole","Carduus marianus","Carduus marianus seed","Carduus versicolor whole","Fruit of silybum marianum","Holy thistle seed","Lady's thistle seed","Mariana lactea whole","Mariana mariana seed","Mary's thistle seed","Milk thistle","Milk thistle fruit","Milk thistle seed","Milk thistle silymarin","Milk thistle whole","Shuifeiji","Silybi fructus","Silybum marianum","Silybum marianum dry fruit","Silybum marianum dry fruit extract","Silybum marianum extract","Silybum marianum fruit","Silybum marianum fruit extract","Silybum marianum seed","Silybum marianum seed extract","Silybum marianum whole","Spotted thistle whole","Variegated thistle whole"],"description":"Unknown drug with a maximum clinical trial phase of II (across all indications) and has 7 investigational indications."}
{"id":"CHEMBL2108938","drugType":"Small molecule","blackBoxWarning":false,"name":"CADEXOMER IODINE","maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Iodoflex","Iodosorb"],"synonyms":["Cadexomer iodine"],"description":"Small molecule drug with a maximum clinical trial phase of IV and is indicated for skin ulcer."}
{"id":"CHEMBL2109005","drugType":"Small molecule","blackBoxWarning":false,"name":"CASTOR OIL","maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":[],"synonyms":["Bimayou","Castor oil","Castor oil, aromatic","Castor oil,emulsion","Castor oil,emulsion,flavored","E-1503","FEMA NO. 2263","Ins no.1503","Ins-1503","Oleum ricini","Ricinus communis fibre oil","Ricinus communis oil","Ricinus communis seed oil","Ricinus zanzibarinus"],"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) and is indicated for constipation and has 1 investigational indication."}
{"id":"CHEMBL2109137","drugType":"Protein","blackBoxWarning":false,"name":"MOROCTOCOG ALFA","maximumClinicalTrialPhase":3,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Moroctocog alfa","Refacto","Refacto-af","Xyntha"],"crossReferences":{"DrugCentral":["5166"]},"description":"Protein drug with a maximum clinical trial phase of III and has 1 investigational indication."}
{"id":"CHEMBL2109287","drugType":"Antibody","blackBoxWarning":false,"name":"TECHNETIUM TC 99M NOFETUMOMAB MERPENTAN","yearOfFirstApproval":1996,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Verluma"],"synonyms":["Nofetumomab","Nofetumomab merpentan 99Tc","Nofetumomab merpentan 99tc","Technetium (99mtc) nofetumomab merpentan","Technetium tc 99m nofetumomab merpentan"],"crossReferences":{"DrugCentral":["5041"]},"description":"Antibody drug with a maximum clinical trial phase of IV that was first approved in 1996."}
{"id":"CHEMBL2109634","drugType":"Antibody","blackBoxWarning":false,"name":"ONCOLYSIN S","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["ONCOLYSIN S"],"description":"Antibody drug with a maximum clinical trial phase of II."}
{"id":"CHEMBL2109647","drugType":"Antibody","blackBoxWarning":false,"name":"REGN-728","maximumClinicalTrialPhase":1,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["REGN-728"],"description":"Antibody drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL2110609","canonicalSmiles":"CCCCCCCCCCCC[N+](CCO)(CCO)Cc1ccccc1","inchiKey":"BTAFSOGRDASALR-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"BENZOXONIUM","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Benzoxonium cation","Benzoxonium ion"],"crossReferences":{"drugbank":["DB13565"]},"childChemblIds":["CHEMBL2104255"],"description":"Small molecule drug with a maximum clinical trial phase of I and has 1 investigational indication."}
{"id":"CHEMBL2110783","canonicalSmiles":"CC(C)(CO)[C@@H](O)C(=O)NCCCC(=O)O","inchiKey":"SBBDHANTMHIRGW-QMMMGPOBSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"HOPANTENIC ACID","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["D-homopantothenic acid","Hopantenic acid","Pantocalcin"],"crossReferences":{"drugbank":["DB14044"]},"childChemblIds":["CHEMBL4303660","CHEMBL2106027"],"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL2110786","canonicalSmiles":"[SrH2]","inchiKey":"KJNGJIPPQOFCSK-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"STRONTIUM","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Strontium"],"childChemblIds":["CHEMBL2106034"],"description":"Small molecule drug with a maximum clinical trial phase of II and has 1 investigational indication."}
{"id":"CHEMBL2110805","canonicalSmiles":"CC[N+](C)(C)C(C)CC(c1ccccc1)c1ccccc1","inchiKey":"JEJBJBKVPOWOQK-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"EMEPRONIUM","maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":[],"synonyms":["Emepronium","Emepronium cation","Emepronium ion"],"crossReferences":{"drugbank":["DB13505"]},"childChemblIds":["CHEMBL2106122"],"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) and is indicated for polyuria and urinary incontinence."}
{"id":"CHEMBL2111083","canonicalSmiles":"CN(C)C(=O)COc1ccc2c(c1)C[C@@H](NC[C@H](O)c1ccc(O)c(CCO)c1)CC2","inchiKey":"OANCEOSLKSTLTA-REWPJTCUSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"BEDORADRINE","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Bedoradrine"],"crossReferences":{"drugbank":["DB05590"]},"childChemblIds":["CHEMBL2218893"],"linkedTargets":{"rows":["ENSG00000169252"],"count":1},"linkedDiseases":{"rows":["EFO_0008590","MONDO_0004979","EFO_0000341"],"count":3},"description":"Small molecule drug with a maximum clinical trial phase of II (across all indications) and has 3 investigational indications."}
{"id":"CHEMBL2111092","canonicalSmiles":"O=S(=O)(O)CCCS(=O)(=O)O","inchiKey":"MGNVWUDMMXZUDI-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"EPRODISATE","maximumClinicalTrialPhase":3,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Eprodisate"],"crossReferences":{"drugbank":["DB06405"]},"childChemblIds":["CHEMBL2107338"],"description":"Small molecule drug with a maximum clinical trial phase of III."}
{"id":"CHEMBL2111164","canonicalSmiles":"O=[N+]([O-])OCCN(CCO[N+](=O)[O-])CCO[N+](=O)[O-]","inchiKey":"HWKQNAWCHQMZHK-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"TROLNITRATE","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Trolnitrate"],"crossReferences":{"PubChem":["144206882"],"drugbank":["DB13719"]},"childChemblIds":["CHEMBL3989711"],"description":"Small molecule drug with a maximum clinical trial phase of I and has 1 investigational indication."}
{"id":"CHEMBL21731","canonicalSmiles":"CNCCCC12CCC(c3ccccc31)c1ccccc12","inchiKey":"QSLMDECMDJKHMQ-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":true,"name":"MAPROTILINE","yearOfFirstApproval":1980,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":[],"synonyms":["BA-34,276 FREE BASE","BA-34,276 [AS HYDROCHLORIDE]","BA-34276 FREE BASE","Maprotiline"],"crossReferences":{"PubChem":["104171192","11111502","11112599","11113802","124880790","124880792","144203751","170464778","26751977","50085871","50104649","90341780"],"Wikipedia":["Maprotiline"],"drugbank":["DB00934"],"chEBI":["6690"]},"childChemblIds":["CHEMBL1237135"],"linkedTargets":{"rows":["ENSG00000103546"],"count":1},"linkedDiseases":{"rows":["MONDO_0005090","MONDO_0002050","HP_0000726","EFO_0003761","EFO_0003833","EFO_0005230","EFO_0000519"],"count":7},"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 1980 and is indicated for unipolar depression and depressive disorder and has 5 investigational indications. This drug has a black box warning from the FDA."}
{"id":"CHEMBL220529","canonicalSmiles":"C[C@@H](C(=O)N1CCOCC1)N1CC[C@H](NS(=O)(=O)c2cc3cc(Cl)ccc3s2)C1=O","inchiKey":"LTJNKFUIOOJXNJ-WFASDCNBSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL220529","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"drugbank":["DB07843"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL223824","canonicalSmiles":"Nc1cccc(CN2C(=O)N(Cc3cccc(N)c3)[C@H](Cc3ccccc3)[C@H](O)[C@@H](O)[C@H]2Cc2ccccc2)c1","inchiKey":"KYRSNWPSSXSNEP-ZRTHHSRSSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"MOZENAVIR","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["DMP-450","Mozenavir"],"crossReferences":{"drugbank":["DB02102"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL2251727","canonicalSmiles":"CCN=C=S","inchiKey":"HBNYJWAFDZLWRS-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"ETHYL ISOTHIOCYANATE","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Ethyl isothiocyanate","FEMA NO. 4420","Isothiocyanic acid, ethyl ester","NSC-84212"],"crossReferences":{"chEBI":["85098"]},"description":"Small molecule drug with a maximum clinical trial phase of II and has 1 investigational indication."}
{"id":"CHEMBL225210","canonicalSmiles":"N[C@H]1CN(CCc2ccc3c(c2)OCO3)C(=O)C[C@@H]1c1cc(F)c(F)cc1F","inchiKey":"DIRIFWIKLRTNMB-DYVFJYSZSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL225210","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"drugbank":["DB07830"]},"childChemblIds":["CHEMBL538090"],"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL259571","canonicalSmiles":"CC(C)c1c(O)cc(/C=C/c2ccccc2)cc1O","inchiKey":"ZISJNXNHJRQYJO-CMDGGOBGSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"TAPINAROF","maximumClinicalTrialPhase":3,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Benvitimod","GSK-2894512","GSK2894512","Tapinarof","WBI-1001","Wbi-1001"],"crossReferences":{"drugbank":["DB06083"]},"linkedTargets":{"rows":["ENSG00000106546"],"count":1},"linkedDiseases":{"rows":["EFO_0000676","EFO_0000274"],"count":2},"description":"Small molecule drug with a maximum clinical trial phase of III (across all indications) and has 2 investigational indications."}
{"id":"CHEMBL269277","canonicalSmiles":"C=C(C)[C@@H]1CC[C@]2(C(=O)O)CC[C@]3(C)[C@H](CC[C@@H]4[C@@]5(C)CC[C@H](O)C(C)(C)[C@@H]5CC[C@]43C)[C@@H]12","inchiKey":"QGJZLNKBHJESQX-FZFNOLFKSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"BETULINIC ACID","maximumClinicalTrialPhase":1,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[".beta.-betulinic acid","ALS-357","Betulic acid","Betulinic acid","Lupatic acid","Mairin","NSC-113090","NSC-677578"],"crossReferences":{"PubChem":["26725276","26756781"],"Wikipedia":["Betulinic_acid"],"drugbank":["DB12480"],"chEBI":["3087"]},"childChemblIds":["CHEMBL1783811","CHEMBL3601028"],"description":"Small molecule drug with a maximum clinical trial phase of I (across all indications) and has 2 investigational indications."}
{"id":"CHEMBL273124","canonicalSmiles":"COc1nc(C(Cl)(Cl)Cl)c(Cl)c(OC)c1Cl","inchiKey":"DZVPGIORVGSQMC-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"PENCLOMEDINE","maximumClinicalTrialPhase":1,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["NSC-338720","Penclomedine"],"crossReferences":{"PubChem":["460965"],"drugbank":["DB12987"]},"description":"Small molecule drug with a maximum clinical trial phase of I (across all indications) and has 2 investigational indications."}
{"id":"CHEMBL287038","canonicalSmiles":"CN(C)CCCNC(=O)c1cccc2c(N)c3ccccc3nc12","inchiKey":"VNWAULKXOPRJEL-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL287038","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"drugbank":["DB02842"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL30","canonicalSmiles":"CN/C(=N/CCSCc1nc[nH]c1C)NC#N","inchiKey":"AQIXAKUUQRKLND-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CIMETIDINE","yearOfFirstApproval":1977,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Acid-eze","Acitak 200","Acitak 400","Acitak 800","Brumetadina","Cimetidine","Dyspamet","Galenamet","Kentamet","Peptimax 200","Peptimax 400","Peptimax 800","Tagadine","Tagamet","Tagamet 100","Tagamet hb","Tagamet hb 200","Ultec","Valmagen","Zita"],"synonyms":["Aciloc","Acinil","Brumetidina","Cimal","Cimetidine","Cimetidinum","Gastromet","NSC-335308","SKF-92334","Stomedine","Ulcedin","Ulcimet","Ulcomedina"],"crossReferences":{"DailyMed":["cimetidine"],"PubChem":["104171130","11113773","11533056","144203657","144208358","170464651","17389962","26747359","26751957","460110","50104629","56462993","90341189"],"TG-GATEs":["35"],"Wikipedia":["Cimetidine"],"drugbank":["DB00501"],"chEBI":["3699"]},"childChemblIds":["CHEMBL1201051"],"linkedTargets":{"rows":["ENSG00000113749"],"count":1},"linkedDiseases":{"rows":["HP_0002239","MONDO_0004658","MONDO_0043839","EFO_0004607","EFO_0000274","EFO_0003948","HP_0004398","MP_0001914","EFO_1001892","EFO_0000544","MONDO_0011962","EFO_0000341","MONDO_0004976","Orphanet_79278"],"count":14},"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 1977 and has 3 approved and 9 investigational indications."}
{"id":"CHEMBL301829","canonicalSmiles":"O=C(O)c1ccc(C(F)(F)F)cc1-c1ccc2c(c1)OC[C@H](Cc1ccccc1)[C@H]2O","inchiKey":"NZQDWKCNBOELAI-KSFYIVLOSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CP-195543","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["CP-195,543","Cp-195,543","Cp-195543"],"crossReferences":{"drugbank":["DB13053"]},"linkedTargets":{"rows":["ENSG00000213903","ENSG00000213906"],"count":2},"linkedDiseases":{"rows":["EFO_0000685"],"count":1},"description":"Small molecule drug with a maximum clinical trial phase of II and has 1 investigational indication."}
{"id":"CHEMBL3039113","canonicalSmiles":"CCNC(=O)CC[C@H](N)C(=O)O","inchiKey":"DATAGRPVKZEWHA-YFKPBYRVSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"THEANINE","maximumClinicalTrialPhase":3,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["L-theanine","NSC-21308","Theanine"],"crossReferences":{"drugbank":["DB12444"],"chEBI":["17394"]},"description":"Small molecule drug with a maximum clinical trial phase of III (across all indications) and has 3 investigational indications."}
{"id":"CHEMBL3087323","canonicalSmiles":"Cc1ncc([N+](=O)[O-])n1CCNS(N)(=O)=O","inchiKey":"AVSMSXHPIYIKIJ-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"DTP-348","maximumClinicalTrialPhase":1,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["DTP348","Dtp-348","Dtp348"],"crossReferences":{"drugbank":["DB12741"]},"description":"Small molecule drug with a maximum clinical trial phase of I and has 1 investigational indication."}
{"id":"CHEMBL3099551","canonicalSmiles":"C[C@H](NC(=O)[C@H](CCC(=O)O)NC(=O)CCCC[C@@H]1CCSS1)C(=O)O","inchiKey":"MQXRTCVZPIHBLD-TUAOUCFPSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CMX-2043","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["(r)-lip-l-glu-l-ala-oh","Cmx-2043","Lip-ea","R-lip-ea-oh"],"crossReferences":{"drugbank":["DB12795"]},"description":"Small molecule drug with a maximum clinical trial phase of II and has 1 investigational indication."}
{"id":"CHEMBL3185786","canonicalSmiles":"CCCCCCCC[Si](OCC)(OCC)OCC","inchiKey":"MSRJTTSHWYDFIU-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL3185786","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"PubChem":["144213951"],"drugbank":["DB11267"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL3260567","canonicalSmiles":"Cc1cccc(-c2[nH]c(CNc3ccccc3F)nc2-c2ccc3ncnn3c2)n1","inchiKey":"FJCDSQATIJKQKA-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"VACTOSERTIB","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Ew-7197","TEW-7197","Tew 7197","Tew-7197","Vactosertib"],"crossReferences":{"drugbank":["DB15310"]},"childChemblIds":["CHEMBL3260908"],"linkedTargets":{"rows":["ENSG00000106799"],"count":1},"linkedDiseases":{"rows":["EFO_0000198","EFO_0000616","EFO_0002618","EFO_0004251","MONDO_0001056","EFO_0003897","EFO_0009907","EFO_0008528","EFO_0001378","EFO_0003060"],"count":10},"description":"Small molecule drug with a maximum clinical trial phase of II (across all indications) and has 10 investigational indications."}
{"id":"CHEMBL330546","canonicalSmiles":"C[C@H](O)C(=O)O","inchiKey":"JVTAAEKCZFNVCJ-REOHCLBHSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"L-LACTIC ACID","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["L-Lactic Acid"],"crossReferences":{"Wikipedia":["Lactic_acid"],"drugbank":["DB14475"],"chEBI":["422"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL331743","canonicalSmiles":"CCOC(=S)SSC(=S)OCC","inchiKey":"FVIGODVHAVLZOO-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"DIXANTHOGEN","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Bis(ethylxanthogen)","Diethyldixanthogen","Diexanthogen","Dixanthogen","NSC-402561"],"crossReferences":{"PubChem":["144212544","29216271"],"Wikipedia":["Dixanthogen"],"drugbank":["DB13712"],"chEBI":["82241"]},"description":"Small molecule drug with a maximum clinical trial phase of I and has 1 investigational indication."}
{"id":"CHEMBL3334824","canonicalSmiles":"CC(C)[C@@H](NC(=O)NCC(C)(C)O)C(=O)N1CC[C@](O)(c2ccc(Cl)cc2)C(C)(C)C1","inchiKey":"GTDPZONCGOCXOD-JPYJTQIMSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"BMS-817399","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["BMS-817399","Bms-817399"],"crossReferences":{"drugbank":["DB14941"]},"linkedTargets":{"rows":["ENSG00000163823"],"count":1},"linkedDiseases":{"rows":["EFO_0000685"],"count":1},"description":"Small molecule drug with a maximum clinical trial phase of II and has 1 investigational indication."}
{"id":"CHEMBL3544906","canonicalSmiles":"C[C@@H](Cc1ccccc1)N(C)Cc1ccccc1.Cl","inchiKey":"ANFSNXAXVLRZCG-RSAXXLAASA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"BENZPHETAMINE HYDROCHLORIDE","yearOfFirstApproval":1960,"maximumClinicalTrialPhase":4,"parentId":"CHEMBL3545985","hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Benzphetamine hydrochloride","Didrex"],"synonyms":["Benzfetamine hydrochloride","Benzphetamine chloride","Benzphetamine hcl","Benzphetamine hydrochloride","Benzphetamine hydrochloride ciii","NSC-10937","U-0441"],"crossReferences":{"DailyMed":["benzphetamine%20hydrochloride"],"chEBI":["59169"]},"linkedTargets":{"rows":["ENSG00000103546","ENSG00000165646"],"count":2},"linkedDiseases":{"rows":["EFO_0001073"],"count":1},"description":"Small molecule drug with a maximum clinical trial phase of IV that was first approved in 1960 and is indicated for obesity."}
{"id":"CHEMBL3545131","drugType":"Antibody","blackBoxWarning":false,"name":"ISATUXIMAB","yearOfFirstApproval":2020,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Sarclisa"],"synonyms":["Isatuximab","Isatuximab-irfc","SAR-650984","SAR650984"],"crossReferences":{"DailyMed":["isatuximab-irfc"]},"linkedTargets":{"rows":["ENSG00000004468"],"count":1},"linkedDiseases":{"rows":["EFO_0000616","EFO_0003073","EFO_0005592","EFO_0000220","EFO_0001642","EFO_0000222","EFO_1001264","EFO_0000540","MONDO_0044881","Orphanet_85443","EFO_1001951","EFO_0000203","MONDO_0044917","EFO_0000574","EFO_0001378"],"count":15},"description":"Antibody drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 2020 and is indicated for multiple myeloma and neoplasm and has 12 investigational indications."}
{"id":"CHEMBL3545229","drugType":"Small molecule","blackBoxWarning":false,"name":"DWP05195","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Dwp05195"],"linkedTargets":{"rows":["ENSG00000196689"],"count":1},"linkedDiseases":{"rows":["MONDO_0041052"],"count":1},"description":"Small molecule drug with a maximum clinical trial phase of II and has 1 investigational indication."}
{"id":"CHEMBL3545413","canonicalSmiles":"Cc1ncc(NC(=O)c2ccc(CN3CCN(C)CC3)c(C(F)(F)F)c2)cc1Nc1nccc(-c2cccnc2)n1","inchiKey":"BJCJYEYYYGBROF-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"FLUMATINIB","maximumClinicalTrialPhase":3,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Flumatinib","Flumbatinib","HH-GV678","Hhgv-678"],"crossReferences":{"drugbank":["DB11904"]},"childChemblIds":["CHEMBL3901539"],"linkedTargets":{"rows":["ENSG00000097007"],"count":1},"linkedDiseases":{"rows":["EFO_0000565","EFO_0000339","EFO_0000220"],"count":3},"description":"Small molecule drug with a maximum clinical trial phase of III (across all indications) and has 2 investigational indications."}
{"id":"CHEMBL355497","canonicalSmiles":"Cc1c(C(=O)c2nccn2C)oc2cccc(OCCCNCc3cccnc3)c12","inchiKey":"VZBQJKIOAOUYJL-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL355497","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"drugbank":["DB03062"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL3616752","canonicalSmiles":"CC[C@H](C)[C@H](NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](CCCCNC(=O)COCCOCCNC(=O)COCCOCCNC(=O)CC[C@@H](NC(=O)CCCCCCCCCCCCCCCCC(=O)O)C(=O)O)NC(=O)[C@H](C)NC(=O)[C@H](C)NC(=O)[C@H](CCC(N)=O)NC(=O)CNC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@H](CO)NC(=O)[C@H](CO)NC(=O)[C@@H](NC(=O)[C@H](CC(=O)O)NC(=O)[C@H](CO)NC(=O)[C@@H](NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@@H](NC(=O)CNC(=O)[C@H](CCC(=O)O)NC(=O)C(C)(C)NC(=O)[C@@H](N)Cc1c[nH]cn1)[C@@H](C)O)[C@@H](C)O)C(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(C)C)C(=O)N[C@H](C(=O)N[C@@H](CCCNC(=N)N)C(=O)NCC(=O)N[C@@H](CCCNC(=N)N)C(=O)NCC(=O)O)C(C)C","inchiKey":"DLSWIYLPEUIQAV-CCUURXOWSA-N","drugType":"Unknown","blackBoxWarning":false,"name":"CHEMBL3616752","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"drugbank":["DB13928"]},"description":"Unknown drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL3707339","canonicalSmiles":"Cc1ncc(COP(=O)(O)O)c(C=O)c1O.NC(=O)CC[C@H](N)C(=O)O","inchiKey":"BCARVEADLDZBJT-HVDRVSQOSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"PYRIDOXAL 5-PHOSPHATE GLUTAMIC ACID","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"childChemblIds":["CHEMBL3707338"],"description":"Small molecule drug with a maximum clinical trial phase of I and has 1 investigational indication."}
{"id":"CHEMBL3707352","drugType":"Small molecule","blackBoxWarning":false,"name":"POLICOSANOL","maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":[],"synonyms":["Policosanol"],"crossReferences":{"DrugCentral":["5074"]},"description":"Small molecule drug with a maximum clinical trial phase of IV and is indicated for cardiovascular disease."}
{"id":"CHEMBL37537","canonicalSmiles":"O=C(O)c1ccc(O)c(O)c1","inchiKey":"YQUVCSBJEUQKSH-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"PROTOCATECHUIC ACID","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Protacatechuic Acid"],"crossReferences":{"PubChem":["144207365","26665736"],"Wikipedia":["Protocatechuic_acid"],"drugbank":["DB03946"],"chEBI":["36062"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL379367","canonicalSmiles":"NC(=O)c1c(NC(=O)C2CC2)sc2c1CCCC2","inchiKey":"VATFNEMGBRWLHI-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL379367","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"drugbank":["DB07398"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL382639","canonicalSmiles":"CCOc1nc(NC(=O)Cc2cc(OC)c(Br)cc2OC)cc(N)c1C#N","inchiKey":"GKODDLYLEKSDJL-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL382639","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"drugbank":["DB07272"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL3894860","canonicalSmiles":"CN1CCN(c2ccc(Nc3ncc4cc5n(c4n3)C3(CCCCC3)CNC5=O)nc2)CC1","inchiKey":"PDGKHKMBHVFCMG-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"TRILACICLIB","yearOfFirstApproval":2021,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":[],"synonyms":["G1T28","Trilaciclib"],"crossReferences":{"drugbank":["DB15442"]},"childChemblIds":["CHEMBL4650272"],"linkedTargets":{"rows":["ENSG00000135446","ENSG00000105810"],"count":2},"linkedDiseases":{"rows":["EFO_0003968","EFO_0005537","MONDO_0007254","EFO_0000702","EFO_0007053","EFO_0003060"],"count":6},"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 2021 and is indicated for small cell lung carcinoma and has 5 investigational indications."}
{"id":"CHEMBL396380","canonicalSmiles":"N[C@@H](CO)[C@@H](O)[C@H](O)[C@H](O)COP(=O)(O)O","inchiKey":"LBNVXZROMBUNNQ-SLPGGIOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL396380","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"drugbank":["DB02445"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL3989551","canonicalSmiles":"CCC[C@@H]1C[C@@H](C(=O)N[C@H]([C@@H](C)O)[C@H]2O[C@H](SC)[C@H](O)[C@@H](O)[C@H]2O)N(C)C1.Cl.O","inchiKey":"LFZGYTBWUHCAKF-DCNJEFSFSA-N","drugType":"Small molecule","blackBoxWarning":true,"name":"LINCOMYCIN HYDROCHLORIDE","yearOfFirstApproval":1964,"maximumClinicalTrialPhase":4,"parentId":"CHEMBL1447","hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Lincocin","Lincomycin hydrochloride"],"synonyms":["Albiotic","Lincolnensin hydrochloride","Lincolnensin hydrochloride monohydrate","Lincomix","Lincomycin (as hydrochloride)","Lincomycin hcl","Lincomycin hydrochloride","Lincomycin hydrochloride anhdrous","Lincomycin hydrochloride hydrate","Lincomycin hydrochloride monohydrate","Lincomycin hydrochloride usp","NSC-70731","NSC-757092"],"crossReferences":{"DailyMed":["lincomycin%20hydrochloride"]},"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 1964 and is indicated for infection and pseudomembranous enterocolitis and has 1 investigational indication. This drug has a black box warning from the FDA."}
{"id":"CHEMBL3989676","canonicalSmiles":"CCCCC1C(=O)N(c2ccccc2)N(c2ccc(O)cc2)C1=O.O","inchiKey":"CNDQSXOVEQXJOE-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"OXYPHENBUTAZONE","yearOfFirstApproval":1960,"maximumClinicalTrialPhase":4,"parentId":"CHEMBL1228","hasBeenWithdrawn":true,"isApproved":true,"withdrawnNotice":{"countries":["United Kingdom"," United States"," Germany"," France"],"classes":["Dermatological toxicity"," Hematological toxicity"],"year":1984},"tradeNames":["Oxyphenbutazone","Tandearil","Tanderil","Tanderil chloramphen"],"synonyms":["NSC-757261","Oxazolidin","Oxiphenbutazone","Oxyphenbutazone","Oxyphenbutazone hydrate","Oxyphenbutazone monohydrate","Phlogase","Phlogistol","Phlogont"],"linkedTargets":{"rows":["ENSG00000073756","ENSG00000095303"],"count":2},"linkedDiseases":{"rows":["HP_0002829","HP_0003326","EFO_0005755","EFO_0005752"],"count":4},"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 1960 and has 4 approved indications. It was withdrawn in United Kingdom,  United States,  Germany and  France initially in 1984 due to Dermatological toxicity and  Hematological toxicity."}
{"id":"CHEMBL3989909","canonicalSmiles":"CCC(=O)N1CC[C@H](Nc2ncnc3c2CN(c2cnc(OC)c(C(F)(F)F)c2)CC3)C1.O=P(O)(O)O","inchiKey":"XXEDEGOAYSGNPS-ZOWNYOTGSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"LENIOLISIB PHOSPHATE","maximumClinicalTrialPhase":2,"parentId":"CHEMBL3643413","hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["CDZ-173","CDZ-173-AZ","CDZ173","CDZ173-AZ","Cdz173","Leniolisib monophosphate","Leniolisib phosphate"],"description":"Small molecule drug with a maximum clinical trial phase of II (across all indications) and has 2 investigational indications."}
{"id":"CHEMBL3989910","canonicalSmiles":"O=C(O)c1ccc(-c2ccc3cc(O)ccc3n2)c(Cl)c1","inchiKey":"BXSZILNGNMDGSL-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CAVOSONSTAT","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Cavosonstat","N-91115","N91115"],"crossReferences":{"drugbank":["DB14775"]},"linkedTargets":{"rows":["ENSG00000197894"],"count":1},"linkedDiseases":{"rows":["Orphanet_586","MONDO_0004979","EFO_0000341"],"count":3},"description":"Small molecule drug with a maximum clinical trial phase of II (across all indications) and has 3 investigational indications."}
{"id":"CHEMBL412262","canonicalSmiles":"CN/C(=N\\S(=O)(=O)c1ccc(Cl)cc1)N1C[C@H](c2ccccc2)C(c2ccc(Cl)cc2)=N1","inchiKey":"AXJQVVLKUYCICH-OAQYLSRUSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"IBIPINABANT","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["BMS-646256","Ibipinabant","SLV-319","Slv319"],"crossReferences":{"drugbank":["DB12649"]},"linkedTargets":{"rows":["ENSG00000118432"],"count":1},"linkedDiseases":{"rows":["MONDO_0005148","EFO_0001073"],"count":2},"description":"Small molecule drug with a maximum clinical trial phase of II (across all indications) and has 2 investigational indications."}
{"id":"CHEMBL412763","canonicalSmiles":"NCCCNCCO[C@H]1[C@H](O[C@@H]2[C@@H](O)[C@H](N)C[C@H](N)[C@H]2O[C@H]2O[C@H](CO)[C@@H](O)[C@H](O)[C@H]2N)O[C@H](CO)[C@H]1O[C@H]1O[C@@H](CN)[C@@H](O)[C@H](O)[C@H]1N","inchiKey":"FJVLHNJZMYGVLT-XXJRHLBLSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL412763","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"drugbank":["DB04717"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL425252","canonicalSmiles":"Nc1ccn([C@@H]2O[C@H](COP(=O)(O)OP(=O)(O)O)[C@@H](O)[C@H]2O)c(=O)n1","inchiKey":"ZWIADYZPOWUWEW-XVFCMESISA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL425252","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"Wikipedia":["Cytidine_diphosphate"],"drugbank":["DB04555"],"chEBI":["17239"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL4297244","drugType":"Oligonucleotide","blackBoxWarning":false,"name":"DANVATIRSEN SODIUM","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["AZD9150 sodium","Danvatirsen pentadecasodium","Danvatirsen sodium"],"description":"Oligonucleotide drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL4297456","canonicalSmiles":"CC(=O)N1CCC[C@H]1C(=O)N[C@@H](Cc1cnc[nH]1)C(=O)N[C@@H](CO)C(=O)N[C@@H](CS)C(=O)N[C@@H](CC(N)=O)C(N)=O","inchiKey":"MMHDBUJXLOFTLC-WOYTXXSLSA-N","drugType":"Protein","blackBoxWarning":false,"name":"ATN-161","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["ATN 161","ATN-161","Ac-phscn-nh2","Atn-161"],"linkedTargets":{"rows":["ENSG00000150093","ENSG00000259207","ENSG00000161638","ENSG00000138448"],"count":4},"linkedDiseases":{"rows":["EFO_0000681","EFO_1000158"],"count":2},"description":"Protein drug with a maximum clinical trial phase of II (across all indications) and has 2 investigational indications."}
{"id":"CHEMBL4297530","canonicalSmiles":"CCO[C@@H](Cc1ccc(OCCn2c(C)ccc2-c2ccc(SC)cc2)cc1)C(=O)O","inchiKey":"MRWFZSLZNUJVQW-DEOSSOPVSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"SAROGLITAZAR","maximumClinicalTrialPhase":3,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Saroglitazar"],"crossReferences":{"drugbank":["DB13115"]},"linkedTargets":{"rows":["ENSG00000186951","ENSG00000132170"],"count":2},"linkedDiseases":{"rows":["EFO_0003086","EFO_0001422","HP_0001397","EFO_0003095","EFO_0001421","EFO_1001249","EFO_1001486","Orphanet_309005"],"count":8},"description":"Small molecule drug with a maximum clinical trial phase of III (across all indications) and has 7 investigational indications."}
{"id":"CHEMBL4297533","canonicalSmiles":"CC(=O)O.CCCC[C@H](NC(C)=O)C(=O)N[C@H]1CC(=O)NCCCC[C@@H](C(=O)O)NC(=O)[C@H](Cc2c[nH]c3ccccc23)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@@H](Cc2ccccc2)NC(=O)[C@H](Cc2c[nH]cn2)NC1=O","inchiKey":"MAYUSRUHXFWITM-GBRHMYBBSA-N","drugType":"Protein","blackBoxWarning":false,"name":"BREMELANOTIDE ACETATE","yearOfFirstApproval":2019,"maximumClinicalTrialPhase":4,"parentId":"CHEMBL2070241","hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Vyleesi (autoinjector)"],"synonyms":["Bremelanotide acetate","PT 141","PT-141","Vyleesi"],"linkedTargets":{"rows":["ENSG00000166603"],"count":1},"linkedDiseases":{"rows":["EFO_0004714","EFO_0000677"],"count":2},"description":"Protein drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 2019 and is indicated for sexual dysfunction and mental or behavioural disorder."}
{"id":"CHEMBL4297707","drugType":"Unknown","blackBoxWarning":false,"name":"BMS-986207","maximumClinicalTrialPhase":1,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Bms-986207"],"description":"Unknown drug with a maximum clinical trial phase of I and has 1 investigational indication."}
{"id":"CHEMBL4297772","drugType":"Unknown","blackBoxWarning":false,"name":"INTERLEUKIN-7","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["CYT107","Cyt 107","Cyt-107","Cyt107","Interleukin 7","Interleukin 7 glycosylated","Interleukin-7","Interleukin-7 human recombinant","Sh-polypeptide-42"],"description":"Unknown drug with a maximum clinical trial phase of II (across all indications) and has 13 investigational indications."}
{"id":"CHEMBL4298037","drugType":"Antibody","blackBoxWarning":false,"name":"RETIFANLIMAB","maximumClinicalTrialPhase":3,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["AEX-1188","AEX1188","INCMGA-00012","INCMGA-0012","INCMGA00012","Incmga00012","MGA-012","MGA012","Mga-012","Mga012","Retifanlimab"],"linkedTargets":{"rows":["ENSG00000188389"],"count":1},"linkedDiseases":{"rows":["EFO_0000616","EFO_0002618","EFO_0006859","EFO_1001901","EFO_0000756","MONDO_0007254","MONDO_0007576","EFO_1001968","EFO_0003060","MONDO_0008315","EFO_0000311","EFO_1001471","EFO_1001480","EFO_1000044","EFO_0005537","MONDO_0011962","EFO_0008528","EFO_1000852","EFO_0000707","EFO_0000691","EFO_0000519","EFO_0000181"],"count":22},"description":"Antibody drug with a maximum clinical trial phase of III (across all indications) and has 18 investigational indications."}
{"id":"CHEMBL4303782","canonicalSmiles":"COc1cc2c(c(OC)n1)[C@]1(O)[C@H](O)[C@H](CN(C)C)[C@@H](c3ccccc3)[C@]1(c1ccc(C#N)cc1)O2","inchiKey":"QYCXWOACFWMQFO-WZWZCULESA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"ZOTATIFIN","maximumClinicalTrialPhase":1,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["EFT-226","EFT226","Eft226","Zotatifin"],"childChemblIds":["CHEMBL4633840"],"description":"Small molecule drug with a maximum clinical trial phase of I (across all indications) and has 2 investigational indications."}
{"id":"CHEMBL436546","canonicalSmiles":"CC(C)c1c(Cc2ccccc2)n(COCc2ccccc2)c(=O)[nH]c1=O","inchiKey":"KSAAUHMSLCPIEX-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"TNK-651","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["TNK-651"],"crossReferences":{"drugbank":["DB08634"],"chEBI":["45910"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL45029","canonicalSmiles":"CCC1(c2ccccc2)C(=O)NC(=O)N(C)C1=O","inchiKey":"ALARQZQTBTVLJV-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"MEPHOBARBITAL","maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Mebaral","Menta-bal","Prominal"],"synonyms":["Enphenemal","Isonal","Mephobarbital","Mephobarbital civ","Methylphenobarbital","Methylphenobarbitone","Metylfenemal","Phemetone"],"crossReferences":{"PubChem":["144205153","29215275"],"Wikipedia":["Methylphenobarbital"],"drugbank":["DB00849"],"chEBI":["6758"]},"description":"Small molecule drug with a maximum clinical trial phase of IV and is indicated for epilepsy."}
{"id":"CHEMBL4594478","drugType":"Gene","blackBoxWarning":false,"name":"INODIFTAGENE VIXTEPLASMID","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Inodiftagene vixteplasmid"],"description":"Gene drug with a maximum clinical trial phase of II and has 1 investigational indication."}
{"id":"CHEMBL4594508","drugType":"Unknown","blackBoxWarning":false,"name":"TRPH-222","maximumClinicalTrialPhase":1,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Anti-cd22 adc trph-222","TRPH-222","Trph-222","Trph222"],"description":"Unknown drug with a maximum clinical trial phase of I (across all indications) and has 3 investigational indications."}
{"id":"CHEMBL4594595","drugType":"Antibody","blackBoxWarning":false,"name":"UBAMATAMAB","maximumClinicalTrialPhase":1,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["REGN-4018","REGN4018","Regn-4018","Regn4018","Ubamatamab"],"description":"Antibody drug with a maximum clinical trial phase of I (across all indications) and has 2 investigational indications."}
{"id":"CHEMBL4594609","drugType":"Unknown","blackBoxWarning":false,"name":"SR-123781A","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["SANORG-123781","SR-123781","SR-123781A","SR123781A","Sr-123781a","Sr123781a"],"description":"Unknown drug with a maximum clinical trial phase of II (across all indications) and has 2 investigational indications."}
{"id":"CHEMBL4650444","drugType":"Unknown","blackBoxWarning":false,"name":"ASP-1948","maximumClinicalTrialPhase":1,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["ASP-1948","ASP1948","Asp-1948","Asp1948","PTZ-329","PTZ329"],"description":"Unknown drug with a maximum clinical trial phase of I and has 1 investigational indication."}
{"id":"CHEMBL4650485","canonicalSmiles":"COc1ccc(F)cc1C(=O)NCc1ccc(-c2nn([C@@H](C)C(F)(F)F)c(N)c2C(N)=O)cc1","inchiKey":"FWZAWAUZXYCBKZ-NSHDSACASA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"PIRTOBRUTINIB","maximumClinicalTrialPhase":3,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["LOXO-305","LY-3527727","LY3527727","Loxo-305","Pirtobrutinib","RXC-005"],"linkedTargets":{"rows":["ENSG00000010671"],"count":1},"linkedDiseases":{"rows":["EFO_0000095","EFO_1001469"],"count":2},"description":"Small molecule drug with a maximum clinical trial phase of III (across all indications) and has 2 investigational indications."}
{"id":"CHEMBL4802183","drugType":"Unknown","blackBoxWarning":false,"name":"TPX-0131","maximumClinicalTrialPhase":1,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["TPX-0131","Tpx-0131"],"description":"Unknown drug with a maximum clinical trial phase of I and has 1 investigational indication."}
{"id":"CHEMBL487738","canonicalSmiles":"NS(=O)(=O)c1ccc(Nc2cncc(Cl)n2)cc1","inchiKey":"RSNSGNZRUMHXAY-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL487738","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"drugbank":["DB08134"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL505851","canonicalSmiles":"CCC1(C2=CC3CCC(C2)C3)C(=O)NC(=O)NC1=O","inchiKey":"MKELYWOVSPVORM-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"REPOSAL","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Reposal","Reposamal","WT-161","Wt161"],"crossReferences":{"Wikipedia":["Reposal"],"drugbank":["DB13805"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL507361","canonicalSmiles":"O=C(NOC[C@H](O)CO)c1ccc(F)c(F)c1Nc1ccc(I)cc1F","inchiKey":"SUDAHWBOROXANE-SECBINFHSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"MIRDAMETINIB","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Mirdametinib","PD-0325901","Pd 0325901","Pd 03525901","Pd 901","Pd-0325901"],"crossReferences":{"PubChem":["144206915"],"drugbank":["DB07101"],"chEBI":["88249"]},"linkedTargets":{"rows":["ENSG00000126934","ENSG00000169032"],"count":2},"linkedDiseases":{"rows":["EFO_0000616","Orphanet_636","MONDO_0021637","EFO_0003060","EFO_1001951","EFO_0000311"],"count":6},"description":"Small molecule drug with a maximum clinical trial phase of II (across all indications) and has 5 investigational indications."}
{"id":"CHEMBL517944","canonicalSmiles":"CCCCCOc1ccc2cc(S(=O)(=O)N[C@H](CCC(=O)O)C(=O)O)ccc2c1","inchiKey":"LIGACKDHLKEZFH-GOSISDBHSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL517944","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"drugbank":["DB08107"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL525076","canonicalSmiles":"CC[C@H](C)[C@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CO)NC(=O)[C@H](Cc1cnc[nH]1)NC(=O)[C@@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CO)NC(=O)[C@@H](NC(=O)[C@H](Cc1ccc(O)cc1)NC(C)=O)[C@@H](C)O)[C@@H](C)CC)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CO)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](C)C(=O)N[C@@H](CO)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](Cc1ccccc1)C(N)=O","inchiKey":"PEASPLKKXBYDKL-FXEVSJAOSA-N","drugType":"Protein","blackBoxWarning":false,"name":"ENFUVIRTIDE","yearOfFirstApproval":2003,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Fuzeon","Fuzeon T-20"],"synonyms":["DP-178","DP178","Enfuvirtide","Fuzeon","Pentafuside (trivial name)","T-20","T20"],"crossReferences":{"DailyMed":["enfuvirtide"],"Wikipedia":["Enfuvirtide"],"chEBI":["608828"]},"childChemblIds":["CHEMBL4085102"],"description":"Protein drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 2003 and has 3 approved and 1 investigational indication."}
{"id":"CHEMBL535396","canonicalSmiles":"CC(N)C12CC3CC(CC(C3)C1)C2.Cl","inchiKey":"OZBDFBJXRJWNAV-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"RIMANTADINE HYDROCHLORIDE","yearOfFirstApproval":1993,"maximumClinicalTrialPhase":4,"parentId":"CHEMBL959","hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Flumadine","Meradan","Rimantadine hydrochloride","Roflual"],"synonyms":["EXP 126","EXP-126","NSC-206764","Rimantadine hcl","Rimantadine hydrochloride"],"crossReferences":{"DailyMed":["rimantadine%20hydrochloride"],"PubChem":["144205265","170465164","26661904"],"chEBI":["8865"]},"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 1993 and is indicated for influenza and infection."}
{"id":"CHEMBL539934","canonicalSmiles":"C[C@@H](O)[C@H](NC(=O)[C@@H]1CSSC[C@H](NC(=O)[C@H](N)Cc2ccccc2)C(=O)N[C@@H](Cc2ccc(O)cc2)C(=O)N[C@H](Cc2c[nH]c3ccccc23)C(=O)N[C@@H](CCCCN)C(=O)N1)C(N)=O","inchiKey":"SNAJPQVDGYDQSW-DYCFWDQMSA-N","drugType":"Protein","blackBoxWarning":false,"name":"TT-232","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["TLN-232","Tln-232","Tt-232"],"crossReferences":{"drugbank":["DB12088"]},"description":"Protein drug with a maximum clinical trial phase of II and has 1 investigational indication."}
{"id":"CHEMBL55643","drugType":"Small molecule","blackBoxWarning":false,"name":"COPPER","maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Cu-7","Paragard t 380a","Tatum-t"],"synonyms":["Bronze powder","C.i. 77400","C.i. pigment metal","Ci 77400","Copper","Copper powder","Copper, elemental","Copper, metallic","Cuprum metallicum"],"crossReferences":{"DailyMed":["copper"],"chEBI":["29036"]},"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) and has 8 investigational indications."}
{"id":"CHEMBL562","canonicalSmiles":"COC1=CC(=O)C[C@@H](C)[C@]12Oc1c(Cl)c(OC)cc(OC)c1C2=O","inchiKey":"DDUHZTYCFQRHIY-RBHXEPJQSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"GRISEOFULVIN","yearOfFirstApproval":1962,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Fulcin","Fulcin 125","Fulcin 500","Fulsovin","Fulvicin","Fulvicin p/g","Fulvicin p/g 165","Fulvicin p/g 330","Fulvicin-p/g","Fulvicin-u/f","Grifulvin","Grifulvin v","Gris-peg","Grisactin","Grisactin ultra","Griseofulvin","Griseofulvin, ultramicrosize","Griseofulvin,ultramicrosize","Grisol af","Grivate","Ultragris-165","Ultragris-330"],"synonyms":["Grisactin v","Griseofulvin","Griseofulvin microsize","Griseofulvin permeability diameter","Griseofulvin, microcrystalline","Griseofulvin, microsize","Griseofulvin, ultramicrocrystalline","Griseofulvin, ultramicrosize","Griseofulvin,microsize","Griseofulvinum","NSC-34533","NSC-755822"],"crossReferences":{"DailyMed":["griseofulvin,%20microsize","griseofulvin,%20ultramicrosize"],"PubChem":["144204638","144209433","144213322","170465739","17389865","26747301","50085968"],"TG-GATEs":["43"],"Wikipedia":["Griseofulvin"],"drugbank":["DB00400"],"chEBI":["27779"]},"childChemblIds":["CHEMBL3794184"],"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 1962 and has 4 approved indications."}
{"id":"CHEMBL567","canonicalSmiles":"OCCN1CCN(CCCN2c3ccccc3Sc3ccc(Cl)cc32)CC1","inchiKey":"RGCVKNLCSQQDEP-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":true,"name":"PERPHENAZINE","yearOfFirstApproval":1957,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Chlorpiprazine","Decentan","Fentazin","Perphenazine","Perphenazine Fendizoate","Trilafon","Trilafon-La"],"synonyms":["Etaperazine","NSC-150866","Perphenazine","Perphenazine fendizoate","Perphenazine maleate"],"crossReferences":{"DailyMed":["perphenazine"],"PubChem":["11111645","11111646","124881147","144203784","170464834","26747080","26747081","50100322","50104233","50104234","56422427","57287811","85231190","856006","90340948"],"Wikipedia":["Perphenazine"],"drugbank":["DB00850"],"chEBI":["8028"]},"linkedTargets":{"rows":["ENSG00000149295"],"count":1},"linkedDiseases":{"rows":["MONDO_0005090","EFO_0002610","MONDO_0002050","HP_0000726","EFO_0000677","HP_0002017","EFO_0005407","EFO_0005230","EFO_0005411","HP_0000713"],"count":10},"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 1957 and has 3 approved and 5 investigational indications. This drug has a black box warning from the FDA."}
{"id":"CHEMBL570","canonicalSmiles":"CN(C)CCCN1c2ccccc2Sc2ccc(C(F)(F)F)cc21","inchiKey":"XSCGXQMFQXDFCW-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"TRIFLUPROMAZINE","yearOfFirstApproval":1957,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Fluopromazine","Nivoman","Vesprin","Vetame"],"synonyms":["Fluopromazine","Triflupromazine"],"crossReferences":{"PubChem":["11111873","11111874","124881619","50100355","50104262","90341005"],"Wikipedia":["Triflupromazine"],"drugbank":["DB00508"],"chEBI":["9711"]},"childChemblIds":["CHEMBL1201102"],"linkedTargets":{"rows":["ENSG00000149295"],"count":1},"linkedDiseases":{"rows":["EFO_0005407"],"count":1},"description":"Small molecule drug with a maximum clinical trial phase of IV that was first approved in 1957 and is indicated for psychosis."}
{"id":"CHEMBL59030","canonicalSmiles":"O=C(O)Cc1cccc(OCCCN(Cc2cccc(C(F)(F)F)c2Cl)CC(c2ccccc2)c2ccccc2)c1","inchiKey":"NAXSRXHZFIBFMI-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"GW3965","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["GW3965"],"crossReferences":{"PubChem":["124892359","26755460"],"drugbank":["DB03791"],"chEBI":["79995"]},"childChemblIds":["CHEMBL4060455"],"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL592943","canonicalSmiles":"CCOC(=O)c1c(N)sc2c1CCN(Cc1ccccc1)C2","inchiKey":"PFENFDGYVLAFBR-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"TINORIDINE","maximumClinicalTrialPhase":3,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["NSC-158555","Tinoridine","Tinoridine hydrochloride","Y 3642","Y-3642"],"crossReferences":{"PubChem":["124892200","144205231","170465864","17441321","29215397"],"drugbank":["DB13001"]},"childChemblIds":["CHEMBL4303244"],"description":"Small molecule drug with a maximum clinical trial phase of III."}
{"id":"CHEMBL593503","canonicalSmiles":"O=C(O)Cc1cc(=O)[nH]c(=O)[nH]1","inchiKey":"NQAUNZZEYKWTHM-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"Uracil-4-Acetic Acid","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Uracil-4-Acetic Acid"],"crossReferences":{"drugbank":["DB03048"],"chEBI":["46371"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL76029","canonicalSmiles":"CC(C)(Oc1ccc(NC(=O)Nc2cc(Cl)cc(Cl)c2)cc1)C(=O)O","inchiKey":"OYJPTSMWFKGZJM-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL76029","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"drugbank":["DB08077"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL919","canonicalSmiles":"O=C1NC(c2ccccc2)(c2ccccc2)C(=O)N1COP(=O)([O-])[O-].[Na+].[Na+]","inchiKey":"GQPXYJNXTAFDLT-UHFFFAOYSA-L","drugType":"Small molecule","blackBoxWarning":true,"name":"FOSPHENYTOIN SODIUM","yearOfFirstApproval":1996,"maximumClinicalTrialPhase":4,"parentId":"CHEMBL1201336","hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Cerebyx","Fosphenytoin sodium","Pro-epanutin","Sesquient"],"synonyms":["ACC-9653-010","ACC-9653-010 (SODIUM SALT)","CI 982","CI-982","Fosphenytoin disodium salt","Fosphenytoin sodium"],"crossReferences":{"DailyMed":["fosphenytoin%20sodium"],"Wikipedia":["Fosphenytoin"]},"linkedTargets":{"rows":["ENSG00000185313","ENSG00000153253","ENSG00000183873","ENSG00000136546","ENSG00000144285","ENSG00000169432","ENSG00000168356","ENSG00000136531","ENSG00000007314","ENSG00000196876"],"count":10},"linkedDiseases":{"rows":["HP_0001250"],"count":1},"description":"Small molecule drug with a maximum clinical trial phase of IV that was first approved in 1996 and is indicated for seizure. This drug has a black box warning from the FDA."}
{"id":"CHEMBL93047","canonicalSmiles":"CCN1C(=O)OC(C)(C)C1=O","inchiKey":"SIGSNYAYBSJATD-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"ETHADIONE","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Epinyl","Ethadione","NSC-27168","Neo-absentol","Petidion","Petisan"],"crossReferences":{"Wikipedia":["Ethadione"],"drugbank":["DB13799"],"chEBI":["81296"]},"description":"Small molecule drug with a maximum clinical trial phase of I and has 1 investigational indication."}
